Ming-Horng Tsai Selected Research

cudraflavone C

7/2017

Cudraflavone C Induces Apoptosis of A375.S2 Melanoma Cells through Mitochondrial ROS Production and MAPK Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Horng Tsai Research Topics

Disease

9	Sepsis (Septicemia) 07/2021 - 11/2009
9	Inflammation (Inflammations) 01/2020 - 11/2009
8	Neoplasms (Cancer) 01/2020 - 05/2011
7	Septic Shock (Toxic Shock Syndrome) 04/2022 - 08/2015
7	Bacteremia 09/2021 - 02/2014
6	Candidemia 04/2022 - 01/2017
5	Respiratory Insufficiency (Respiratory Failure) 04/2021 - 05/2009
5	Infections 11/2018 - 12/2010
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016 - 01/2011
3	Meningitis 10/2021 - 03/2016
3	Ventilator-Associated Pneumonia 10/2020 - 03/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2017
2	Critical Illness (Critically Ill) 04/2021 - 04/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019 - 04/2017
2	Renal Insufficiency (Renal Failure) 01/2018 - 01/2017
2	Cholestasis 01/2018 - 02/2013
2	Melanoma (Melanoma, Malignant) 07/2017 - 01/2014
2	Phlebitis 12/2010 - 11/2009
1	Cross Infection (Nosocomial Infection) 04/2021
1	Rheumatoid Arthritis 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Mouth Neoplasms (Oral Cancer) 01/2020
1	Non-alcoholic Fatty Liver Disease 11/2019
1	Pulmonary Hypertension 07/2019
1	Hypoxia (Hypoxemia) 07/2019
1	Bronchopulmonary Dysplasia 07/2019
1	Persistent Fetal Circulation Syndrome 07/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Heart Failure 01/2019
1	Myocarditis (Carditis) 01/2019
1	Glioma (Gliomas) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Bacterial Meningitis 01/2018
1	Invasive Candidiasis 01/2018
1	Atherosclerosis 03/2017
1	Necrotizing Enterocolitis 01/2017
1	Skin Diseases (Skin Disease) 08/2016

Drug/Important Bio-Agent (IBA)

11	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 12/2008
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
4	Particulate MatterIBA 01/2020 - 01/2016
4	eupafolinIBA 08/2016 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2018
3	artocarpin lectinIBA 05/2019 - 04/2017
3	FlavonoidsIBA 05/2019 - 04/2017
3	Central Nervous System StimulantsIBA 12/2013 - 01/2011
2	Antifungal AgentsIBA 04/2022 - 10/2018
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
2	EchinocandinsIBA 01/2019 - 10/2018
2	Dinoprostone (PGE2)FDA Link 11/2018 - 01/2016
2	tricarbonyldichlororuthenium (II) dimerIBA 11/2018 - 01/2017
2	p38 Mitogen-Activated Protein KinasesIBA 11/2018 - 01/2014
2	Fluconazole (Zonal)FDA LinkGeneric 10/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 09/2014
2	AntioxidantsIBA 08/2016 - 01/2016
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2016 - 12/2008
2	Methylphenidate (Ritalin)FDA LinkGeneric 12/2013 - 01/2011
1	Therapeutic UsesIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	surfactin AIBA 01/2020
1	LipopeptidesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 11/2019
1	LipidsIBA 11/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	SteroidsIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2018
1	AzolesIBA 10/2018
1	Matrix Metalloproteinase 13IBA 01/2018
1	thrombospondin 2IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	cudraflavone CIBA 07/2017
1	magnololIBA 03/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017
1	Air Pollutants (Pollutants, Air)IBA 08/2016
1	MelatoninIBA 01/2016
1	Guanfacine (Tenex)FDA LinkGeneric 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2016
1	CosmeceuticalsIBA 01/2016
1	NADP (NADPH)IBA 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016

Therapy/Procedure

16	Therapeutics 04/2021 - 12/2008
8	Catheters 04/2022 - 11/2009
6	Mechanical Ventilators (Ventilator) 09/2021 - 12/2010
3	Central Venous Catheters 12/2018 - 12/2010
2	Drug Therapy (Chemotherapy) 01/2016 - 05/2006
1	Off-Label Use 07/2019
1	Intra-Aortic Balloon Pumping 01/2019
1	Extracorporeal Membrane Oxygenation 01/2019
1	Aftercare (After-Treatment) 01/2018